top of page

Our
Publications

In collaboration with: University of Antwerp, University Hospital Antwerp (UZA), Medical University of Vienna

Molecular Cancer • Mar. 29, 2026

[18F]FDG PET/CT multiomics identifies Hedgehog-driven HPV-negative head and neck squamous cell carcinoma

HNSCC paper.jpg

Communications Biology • Dec. 03, 2024

Development and validation of the Normalized Organoid Growth Rate (NOGR) metric in brightfield imaging-based assays

Journal of Experimental & Clinical Cancer Research • Mar. 22, 2024

Auranofin repurposing for lung and pancreatic cancer: low CA12 expression as a marker of sensitivity in patient-derived organoids, with potentiated efficacy by AKT inhibition

Auranofin paper.jpg

Journal of Translational Medicine • Mar. 3, 2024

CRISPR/Cas9-edited ROS1 + non-small cell lung cancer cell lines highlight differential drug sensitivity in 2D vs 3D cultures while reflecting established resistance profiles

CRISPR paper.jpg

Journal of Hematology & Oncology • Feb. 9, 2024

IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts

CARNK paper.jpg

npj Precision Oncology • Dec. 8, 2023

Single-organoid analysis reveals clinically relevant treatment-resistant and invasive subclones in pancreatic cancer

patient response.png

JoVE • Dec. 23, 2022

Multiparametric tumor organoid drug screening using widefield live-cell imaging for bulk and single-organoid analysis

Cellular Oncology • Dec. 12, 2022

OrBITS: label-free and time-lapse monitoring of patient derived organoids for advanced drug screening

Cellular Oncology_edited_edited.jpg

Abstracte lijnen

Ready to unlock organoid insights?

Sign up for the waitlist or contact us directly

bottom of page